Gail Folena-Wasserman
Profile
Gail Folena-Wasserman had been Senior Vice President of Development for MedImmune, Inc. since February 2002.
She joined MedImmune, Inc. in 1991 as Director of Development.
She held various positions at SmithKline Beecham Pharmaceuticals.
She received a Bachelor's degree from Montclair State University in New Jersey and a Master's degree and a Doctorate degree from Pennsylvania State University.
Former positions of Gail Folena-Wasserman
| Companies | Position | End |
|---|---|---|
Virdante Pharmaceuticals, Inc.
 Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Virdante Pharmaceuticals, Inc. develops and commercializes drugs for auto-immune and inflammatory disorders. The company's products incorporate a proprietary 'sialic switch' technology to improve the anti-inflammatory properties of antibodies. It was founded in 2008 and is headquartered in Cambridge, MA. | Director/Board Member | 30/01/2012 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Corporate Officer/Principal | - |
Training of Gail Folena-Wasserman
| Montclair State University | Undergraduate Degree |
| The Pennsylvania State University | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Virdante Pharmaceuticals, Inc.
Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Virdante Pharmaceuticals, Inc. develops and commercializes drugs for auto-immune and inflammatory disorders. The company's products incorporate a proprietary 'sialic switch' technology to improve the anti-inflammatory properties of antibodies. It was founded in 2008 and is headquartered in Cambridge, MA. | Distribution Services |
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
- Stock Market
- Insiders
- Gail Folena-Wasserman
